科研之友
微信
新浪微博
Facebook
分享链接
摘要
Prothymosin alpha (ProT), a nuclear protein, is implicated in the inhibition of ischemia-induced necrosis as well as apoptosis in the brain and retina. Although ProT has multiple biological functions through distinct regions in its sequence, it has remained which region is involved in this neuroprotection. This study reported that the active core peptide sequence P30 (amino acids 4978) of ProT exerts its full survival effect in cultured cortical neurons against ischemic stress. Our in vivo study revealed that intravitreous administration of P30 at 24h after retinal ischemia significantly blocks the ischemia-induced functional damages of retina at day7. In addition, P30 completely rescued the retinal ischemia-induced ganglion cell damages at day7 after the ischemic stress, along with partial blockade of the loss of bipolar, amacrine, and photoreceptor cells. On the other hand, intracerebroventricular (3nmol) or systemic (1mg/kg; i.v.) injection of P30 at 1h after cerebral ischemia (1h tMCAO) significantly blocked the ischemia-induced brain damages and disruption of blood vessels. Systemic P30 delivery (1mg/kg; i.v.) also significantly ameliorated the ischemic brain caused by photochemically induced thrombosis. Taken together, this study confers a precise demonstration about the novel protective activity of ProT-derived small peptide P30 against the ischemic damages in vitro and in vivo.
- 出版日期2013-6
